カテゴリー： 世界, 医療/バイオ, LP Information

世界のアミカシン原薬市場予測 2023年-2029年

【英語タイトル】Global Amikacin API Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC07764）・商品コード：LP23DC07764
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：91
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のアミカシン原薬市場」は、過去の販売実績から2022年の世界のアミカシン原薬の総販売量を検討し、2023年から2029年の予測されるアミカシン原薬の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のアミカシン原薬の市場規模を掲載し、XXX百万米ドル規模の世界のアミカシン原薬市場の詳細な分析を提供します。本インサイトレポートは、世界のアミカシン原薬業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のアミカシン原薬市場における各社の独自のポジションをより深く理解するために、アミカシン原薬製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のアミカシン原薬市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。アミカシン原薬の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。アミカシン原薬の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。アミカシン原薬のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

アミカシン原薬の世界主要メーカーとしては、Wellona Pharma、 VEA Impex、 Qilu Pharma、 Zhejiang Jinhua Conba、 Zhejiang Yongning Pharma、 Sichuan Renan Pharma、 Chongqing Daxin Pharma、 Jiangsu Wuzhong Pharmaなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のアミカシン原薬市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではアミカシン原薬市場をセグメンテーションし、種類別 (アミカシン、硫酸アミカシン)、用途別 (注射剤、経口剤)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：アミカシン、硫酸アミカシン

・用途別区分：注射剤、経口剤

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のアミカシン原薬市場の10年間の市場状況・展望は？
・世界および地域別に見たアミカシン原薬市場成長の要因は何か？
・アミカシン原薬の市場機会はエンドマーケットの規模によってどのように変化するのか？
・アミカシン原薬のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：アミカシン原薬の年間販売量2018-2029、地域別現状・将来分析
・アミカシン原薬の種類別セグメント：アミカシン、硫酸アミカシン
・アミカシン原薬の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・アミカシン原薬の用途別セグメント：注射剤、経口剤
・アミカシン原薬の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のアミカシン原薬市場
・企業別のグローバルアミカシン原薬市場データ：2018-2023年の年間販売量、市場シェア
・企業別のアミカシン原薬の年間売上：2018-2023年の売上、市場シェア
・企業別のアミカシン原薬販売価格
・主要企業のアミカシン原薬生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

アミカシン原薬の地域別レビュー
・地域別のアミカシン原薬市場規模2018-2023：年間販売量、売上
・主要国別のアミカシン原薬市場規模2018-2023：年間販売量、売上
・南北アメリカのアミカシン原薬販売の成長
・アジア太平洋のアミカシン原薬販売の成長
・ヨーロッパのアミカシン原薬販売の成長
・中東・アフリカのアミカシン原薬販売の成長

南北アメリカ市場
・南北アメリカの国別のアミカシン原薬販売量、売上（2018-2023）
・南北アメリカのアミカシン原薬の種類別販売量
・南北アメリカのアミカシン原薬の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のアミカシン原薬販売量、売上（2018-2023）
・アジア太平洋のアミカシン原薬の種類別販売量
・アジア太平洋のアミカシン原薬の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のアミカシン原薬販売量、売上（2018-2023）
・ヨーロッパのアミカシン原薬の種類別販売量
・ヨーロッパのアミカシン原薬の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のアミカシン原薬販売量、売上（2018-2023）
・中東・アフリカのアミカシン原薬の種類別販売量
・中東・アフリカのアミカシン原薬の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・アミカシン原薬の製造コスト構造分析
・アミカシン原薬の製造プロセス分析
・アミカシン原薬の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・アミカシン原薬の主要なグローバル販売業者
・アミカシン原薬の主要なグローバル顧客

地域別のアミカシン原薬市場予測レビュー
・地域別のアミカシン原薬市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・アミカシン原薬の種類別市場規模予測
・アミカシン原薬の用途別市場規模予測

主要企業分析
Wellona Pharma、 VEA Impex、 Qilu Pharma、 Zhejiang Jinhua Conba、 Zhejiang Yongning Pharma、 Sichuan Renan Pharma、 Chongqing Daxin Pharma、 Jiangsu Wuzhong Pharma
・企業情報
・アミカシン原薬製品
・アミカシン原薬販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Amikacin API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Amikacin API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Amikacin API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Amikacin API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Amikacin API players cover Wellona Pharma, VEA Impex, Qilu Pharma, Zhejiang Jinhua Conba, Zhejiang Yongning Pharma, Sichuan Renan Pharma, Chongqing Daxin Pharma and Jiangsu Wuzhong Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Amikacin API Industry Forecast” looks at past sales and reviews total world Amikacin API sales in 2022, providing a comprehensive analysis by region and market sector of projected Amikacin API sales for 2023 through 2029. With Amikacin API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amikacin API industry.
This Insight Report provides a comprehensive analysis of the global Amikacin API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Amikacin API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Amikacin API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amikacin API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amikacin API.
This report presents a comprehensive overview, market shares, and growth opportunities of Amikacin API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Amikacin
Amikacin Sulfate
Segmentation by application
Injection
Oral
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Wellona Pharma
VEA Impex
Qilu Pharma
Zhejiang Jinhua Conba
Zhejiang Yongning Pharma
Sichuan Renan Pharma
Chongqing Daxin Pharma
Jiangsu Wuzhong Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Amikacin API market?
What factors are driving Amikacin API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Amikacin API market opportunities vary by end market size?
How does Amikacin API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Amikacin API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Amikacin API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Amikacin API by Country/Region, 2018, 2022 & 2029
2.2 Amikacin API Segment by Type
2.2.1 Amikacin
2.2.2 Amikacin Sulfate
2.3 Amikacin API Sales by Type
2.3.1 Global Amikacin API Sales Market Share by Type (2018-2023)
2.3.2 Global Amikacin API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Amikacin API Sale Price by Type (2018-2023)
2.4 Amikacin API Segment by Application
2.4.1 Injection
2.4.2 Oral
2.5 Amikacin API Sales by Application
2.5.1 Global Amikacin API Sale Market Share by Application (2018-2023)
2.5.2 Global Amikacin API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Amikacin API Sale Price by Application (2018-2023)
3 Global Amikacin API by Company
3.1 Global Amikacin API Breakdown Data by Company
3.1.1 Global Amikacin API Annual Sales by Company (2018-2023)
3.1.2 Global Amikacin API Sales Market Share by Company (2018-2023)
3.2 Global Amikacin API Annual Revenue by Company (2018-2023)
3.2.1 Global Amikacin API Revenue by Company (2018-2023)
3.2.2 Global Amikacin API Revenue Market Share by Company (2018-2023)
3.3 Global Amikacin API Sale Price by Company
3.4 Key Manufacturers Amikacin API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Amikacin API Product Location Distribution
3.4.2 Players Amikacin API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Amikacin API by Geographic Region
4.1 World Historic Amikacin API Market Size by Geographic Region (2018-2023)
4.1.1 Global Amikacin API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Amikacin API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Amikacin API Market Size by Country/Region (2018-2023)
4.2.1 Global Amikacin API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Amikacin API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Amikacin API Sales Growth
4.4 APAC Amikacin API Sales Growth
4.5 Europe Amikacin API Sales Growth
4.6 Middle East & Africa Amikacin API Sales Growth
5 Americas
5.1 Americas Amikacin API Sales by Country
5.1.1 Americas Amikacin API Sales by Country (2018-2023)
5.1.2 Americas Amikacin API Revenue by Country (2018-2023)
5.2 Americas Amikacin API Sales by Type
5.3 Americas Amikacin API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Amikacin API Sales by Region
6.1.1 APAC Amikacin API Sales by Region (2018-2023)
6.1.2 APAC Amikacin API Revenue by Region (2018-2023)
6.2 APAC Amikacin API Sales by Type
6.3 APAC Amikacin API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Amikacin API by Country
7.1.1 Europe Amikacin API Sales by Country (2018-2023)
7.1.2 Europe Amikacin API Revenue by Country (2018-2023)
7.2 Europe Amikacin API Sales by Type
7.3 Europe Amikacin API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Amikacin API by Country
8.1.1 Middle East & Africa Amikacin API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Amikacin API Revenue by Country (2018-2023)
8.2 Middle East & Africa Amikacin API Sales by Type
8.3 Middle East & Africa Amikacin API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Amikacin API
10.3 Manufacturing Process Analysis of Amikacin API
10.4 Industry Chain Structure of Amikacin API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Amikacin API Distributors
11.3 Amikacin API Customer
12 World Forecast Review for Amikacin API by Geographic Region
12.1 Global Amikacin API Market Size Forecast by Region
12.1.1 Global Amikacin API Forecast by Region (2024-2029)
12.1.2 Global Amikacin API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Amikacin API Forecast by Type
12.7 Global Amikacin API Forecast by Application
13 Key Players Analysis
13.1 Wellona Pharma
13.1.1 Wellona Pharma Company Information
13.1.2 Wellona Pharma Amikacin API Product Portfolios and Specifications
13.1.3 Wellona Pharma Amikacin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Wellona Pharma Main Business Overview
13.1.5 Wellona Pharma Latest Developments
13.2 VEA Impex
13.2.1 VEA Impex Company Information
13.2.2 VEA Impex Amikacin API Product Portfolios and Specifications
13.2.3 VEA Impex Amikacin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 VEA Impex Main Business Overview
13.2.5 VEA Impex Latest Developments
13.3 Qilu Pharma
13.3.1 Qilu Pharma Company Information
13.3.2 Qilu Pharma Amikacin API Product Portfolios and Specifications
13.3.3 Qilu Pharma Amikacin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Qilu Pharma Main Business Overview
13.3.5 Qilu Pharma Latest Developments
13.4 Zhejiang Jinhua Conba
13.4.1 Zhejiang Jinhua Conba Company Information
13.4.2 Zhejiang Jinhua Conba Amikacin API Product Portfolios and Specifications
13.4.3 Zhejiang Jinhua Conba Amikacin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Zhejiang Jinhua Conba Main Business Overview
13.4.5 Zhejiang Jinhua Conba Latest Developments
13.5 Zhejiang Yongning Pharma
13.5.1 Zhejiang Yongning Pharma Company Information
13.5.2 Zhejiang Yongning Pharma Amikacin API Product Portfolios and Specifications
13.5.3 Zhejiang Yongning Pharma Amikacin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Zhejiang Yongning Pharma Main Business Overview
13.5.5 Zhejiang Yongning Pharma Latest Developments
13.6 Sichuan Renan Pharma
13.6.1 Sichuan Renan Pharma Company Information
13.6.2 Sichuan Renan Pharma Amikacin API Product Portfolios and Specifications
13.6.3 Sichuan Renan Pharma Amikacin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Sichuan Renan Pharma Main Business Overview
13.6.5 Sichuan Renan Pharma Latest Developments
13.7 Chongqing Daxin Pharma
13.7.1 Chongqing Daxin Pharma Company Information
13.7.2 Chongqing Daxin Pharma Amikacin API Product Portfolios and Specifications
13.7.3 Chongqing Daxin Pharma Amikacin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Chongqing Daxin Pharma Main Business Overview
13.7.5 Chongqing Daxin Pharma Latest Developments
13.8 Jiangsu Wuzhong Pharma
13.8.1 Jiangsu Wuzhong Pharma Company Information
13.8.2 Jiangsu Wuzhong Pharma Amikacin API Product Portfolios and Specifications
13.8.3 Jiangsu Wuzhong Pharma Amikacin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Jiangsu Wuzhong Pharma Main Business Overview
13.8.5 Jiangsu Wuzhong Pharma Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Amikacin API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Amikacin API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Amikacin
Table 4. Major Players of Amikacin Sulfate
Table 5. Global Amikacin API Sales by Type (2018-2023) & (Tons)
Table 6. Global Amikacin API Sales Market Share by Type (2018-2023)
Table 7. Global Amikacin API Revenue by Type (2018-2023) & ($ million)
Table 8. Global Amikacin API Revenue Market Share by Type (2018-2023)
Table 9. Global Amikacin API Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Amikacin API Sales by Application (2018-2023) & (Tons)
Table 11. Global Amikacin API Sales Market Share by Application (2018-2023)
Table 12. Global Amikacin API Revenue by Application (2018-2023)
Table 13. Global Amikacin API Revenue Market Share by Application (2018-2023)
Table 14. Global Amikacin API Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Amikacin API Sales by Company (2018-2023) & (Tons)
Table 16. Global Amikacin API Sales Market Share by Company (2018-2023)
Table 17. Global Amikacin API Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Amikacin API Revenue Market Share by Company (2018-2023)
Table 19. Global Amikacin API Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Amikacin API Producing Area Distribution and Sales Area
Table 21. Players Amikacin API Products Offered
Table 22. Amikacin API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Amikacin API Sales by Geographic Region (2018-2023) & (Tons)
Table 26. Global Amikacin API Sales Market Share Geographic Region (2018-2023)
Table 27. Global Amikacin API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Amikacin API Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Amikacin API Sales by Country/Region (2018-2023) & (Tons)
Table 30. Global Amikacin API Sales Market Share by Country/Region (2018-2023)
Table 31. Global Amikacin API Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Amikacin API Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Amikacin API Sales by Country (2018-2023) & (Tons)
Table 34. Americas Amikacin API Sales Market Share by Country (2018-2023)
Table 35. Americas Amikacin API Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Amikacin API Revenue Market Share by Country (2018-2023)
Table 37. Americas Amikacin API Sales by Type (2018-2023) & (Tons)
Table 38. Americas Amikacin API Sales by Application (2018-2023) & (Tons)
Table 39. APAC Amikacin API Sales by Region (2018-2023) & (Tons)
Table 40. APAC Amikacin API Sales Market Share by Region (2018-2023)
Table 41. APAC Amikacin API Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Amikacin API Revenue Market Share by Region (2018-2023)
Table 43. APAC Amikacin API Sales by Type (2018-2023) & (Tons)
Table 44. APAC Amikacin API Sales by Application (2018-2023) & (Tons)
Table 45. Europe Amikacin API Sales by Country (2018-2023) & (Tons)
Table 46. Europe Amikacin API Sales Market Share by Country (2018-2023)
Table 47. Europe Amikacin API Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Amikacin API Revenue Market Share by Country (2018-2023)
Table 49. Europe Amikacin API Sales by Type (2018-2023) & (Tons)
Table 50. Europe Amikacin API Sales by Application (2018-2023) & (Tons)
Table 51. Middle East & Africa Amikacin API Sales by Country (2018-2023) & (Tons)
Table 52. Middle East & Africa Amikacin API Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Amikacin API Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Amikacin API Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Amikacin API Sales by Type (2018-2023) & (Tons)
Table 56. Middle East & Africa Amikacin API Sales by Application (2018-2023) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of Amikacin API
Table 58. Key Market Challenges & Risks of Amikacin API
Table 59. Key Industry Trends of Amikacin API
Table 60. Amikacin API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Amikacin API Distributors List
Table 63. Amikacin API Customer List
Table 64. Global Amikacin API Sales Forecast by Region (2024-2029) & (Tons)
Table 65. Global Amikacin API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Amikacin API Sales Forecast by Country (2024-2029) & (Tons)
Table 67. Americas Amikacin API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Amikacin API Sales Forecast by Region (2024-2029) & (Tons)
Table 69. APAC Amikacin API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Amikacin API Sales Forecast by Country (2024-2029) & (Tons)
Table 71. Europe Amikacin API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Amikacin API Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Middle East & Africa Amikacin API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Amikacin API Sales Forecast by Type (2024-2029) & (Tons)
Table 75. Global Amikacin API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Amikacin API Sales Forecast by Application (2024-2029) & (Tons)
Table 77. Global Amikacin API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Wellona Pharma Basic Information, Amikacin API Manufacturing Base, Sales Area and Its Competitors
Table 79. Wellona Pharma Amikacin API Product Portfolios and Specifications
Table 80. Wellona Pharma Amikacin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. Wellona Pharma Main Business
Table 82. Wellona Pharma Latest Developments
Table 83. VEA Impex Basic Information, Amikacin API Manufacturing Base, Sales Area and Its Competitors
Table 84. VEA Impex Amikacin API Product Portfolios and Specifications
Table 85. VEA Impex Amikacin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. VEA Impex Main Business
Table 87. VEA Impex Latest Developments
Table 88. Qilu Pharma Basic Information, Amikacin API Manufacturing Base, Sales Area and Its Competitors
Table 89. Qilu Pharma Amikacin API Product Portfolios and Specifications
Table 90. Qilu Pharma Amikacin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Qilu Pharma Main Business
Table 92. Qilu Pharma Latest Developments
Table 93. Zhejiang Jinhua Conba Basic Information, Amikacin API Manufacturing Base, Sales Area and Its Competitors
Table 94. Zhejiang Jinhua Conba Amikacin API Product Portfolios and Specifications
Table 95. Zhejiang Jinhua Conba Amikacin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Zhejiang Jinhua Conba Main Business
Table 97. Zhejiang Jinhua Conba Latest Developments
Table 98. Zhejiang Yongning Pharma Basic Information, Amikacin API Manufacturing Base, Sales Area and Its Competitors
Table 99. Zhejiang Yongning Pharma Amikacin API Product Portfolios and Specifications
Table 100. Zhejiang Yongning Pharma Amikacin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Zhejiang Yongning Pharma Main Business
Table 102. Zhejiang Yongning Pharma Latest Developments
Table 103. Sichuan Renan Pharma Basic Information, Amikacin API Manufacturing Base, Sales Area and Its Competitors
Table 104. Sichuan Renan Pharma Amikacin API Product Portfolios and Specifications
Table 105. Sichuan Renan Pharma Amikacin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Sichuan Renan Pharma Main Business
Table 107. Sichuan Renan Pharma Latest Developments
Table 108. Chongqing Daxin Pharma Basic Information, Amikacin API Manufacturing Base, Sales Area and Its Competitors
Table 109. Chongqing Daxin Pharma Amikacin API Product Portfolios and Specifications
Table 110. Chongqing Daxin Pharma Amikacin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Chongqing Daxin Pharma Main Business
Table 112. Chongqing Daxin Pharma Latest Developments
Table 113. Jiangsu Wuzhong Pharma Basic Information, Amikacin API Manufacturing Base, Sales Area and Its Competitors
Table 114. Jiangsu Wuzhong Pharma Amikacin API Product Portfolios and Specifications
Table 115. Jiangsu Wuzhong Pharma Amikacin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. Jiangsu Wuzhong Pharma Main Business
Table 117. Jiangsu Wuzhong Pharma Latest Developments
List of Figures
Figure 1. Picture of Amikacin API
Figure 2. Amikacin API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Amikacin API Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Amikacin API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Amikacin API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Amikacin
Figure 10. Product Picture of Amikacin Sulfate
Figure 11. Global Amikacin API Sales Market Share by Type in 2022
Figure 12. Global Amikacin API Revenue Market Share by Type (2018-2023)
Figure 13. Amikacin API Consumed in Injection
Figure 14. Global Amikacin API Market: Injection (2018-2023) & (Tons)
Figure 15. Amikacin API Consumed in Oral
Figure 16. Global Amikacin API Market: Oral (2018-2023) & (Tons)
Figure 17. Global Amikacin API Sales Market Share by Application (2022)
Figure 18. Global Amikacin API Revenue Market Share by Application in 2022
Figure 19. Amikacin API Sales Market by Company in 2022 (Tons)
Figure 20. Global Amikacin API Sales Market Share by Company in 2022
Figure 21. Amikacin API Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Amikacin API Revenue Market Share by Company in 2022
Figure 23. Global Amikacin API Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Amikacin API Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Amikacin API Sales 2018-2023 (Tons)
Figure 26. Americas Amikacin API Revenue 2018-2023 ($ Millions)
Figure 27. APAC Amikacin API Sales 2018-2023 (Tons)
Figure 28. APAC Amikacin API Revenue 2018-2023 ($ Millions)
Figure 29. Europe Amikacin API Sales 2018-2023 (Tons)
Figure 30. Europe Amikacin API Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Amikacin API Sales 2018-2023 (Tons)
Figure 32. Middle East & Africa Amikacin API Revenue 2018-2023 ($ Millions)
Figure 33. Americas Amikacin API Sales Market Share by Country in 2022
Figure 34. Americas Amikacin API Revenue Market Share by Country in 2022
Figure 35. Americas Amikacin API Sales Market Share by Type (2018-2023)
Figure 36. Americas Amikacin API Sales Market Share by Application (2018-2023)
Figure 37. United States Amikacin API Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Amikacin API Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Amikacin API Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Amikacin API Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Amikacin API Sales Market Share by Region in 2022
Figure 42. APAC Amikacin API Revenue Market Share by Regions in 2022
Figure 43. APAC Amikacin API Sales Market Share by Type (2018-2023)
Figure 44. APAC Amikacin API Sales Market Share by Application (2018-2023)
Figure 45. China Amikacin API Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Amikacin API Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Amikacin API Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Amikacin API Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Amikacin API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Amikacin API Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Amikacin API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Amikacin API Sales Market Share by Country in 2022
Figure 53. Europe Amikacin API Revenue Market Share by Country in 2022
Figure 54. Europe Amikacin API Sales Market Share by Type (2018-2023)
Figure 55. Europe Amikacin API Sales Market Share by Application (2018-2023)
Figure 56. Germany Amikacin API Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Amikacin API Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Amikacin API Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Amikacin API Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Amikacin API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Amikacin API Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Amikacin API Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Amikacin API Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Amikacin API Sales Market Share by Application (2018-2023)
Figure 65. Egypt Amikacin API Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Amikacin API Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Amikacin API Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Amikacin API Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Amikacin API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Amikacin API in 2022
Figure 71. Manufacturing Process Analysis of Amikacin API
Figure 72. Industry Chain Structure of Amikacin API
Figure 73. Channels of Distribution
Figure 74. Global Amikacin API Sales Market Forecast by Region (2024-2029)
Figure 75. Global Amikacin API Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Amikacin API Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Amikacin API Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Amikacin API Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Amikacin API Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のアミカシン原薬市場予測 2023年-2029年] (コード：LP23DC07764)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のアミカシン原薬市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の硫酸アミカシン原薬市場予測 2023年-2029年
  • 世界の医薬品用セフィキシム市場予測 2023年-2029年
  • 世界の製薬用チューブ市場予測 2023年-2029年
  • 世界のベンダゾール錠市場予測 2023年-2029年
  • 世界のアモキシシリンナトリウム原薬市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆